3p0g
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | [[ | + | ==Structure of a nanobody-stabilized active state of the beta2 adrenoceptor== |
+ | <StructureSection load='3p0g' size='340' side='right' caption='[[3p0g]], [[Resolution|resolution]] 3.50Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[3p0g]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Enterobacteria_phage_t4 Enterobacteria phage t4] and [http://en.wikipedia.org/wiki/Lama_glama Lama glama]. The April 2011 RCSB PDB [http://pdb.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/index.html Molecule of the Month] feature on ''Nanobodies'' by David Goodsell is [http://dx.doi.org/10.2210/rcsb_pdb/mom_2011_4 10.2210/rcsb_pdb/mom_2011_4]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3P0G OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3P0G FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P0G:8-[(1R)-2-{[1,1-DIMETHYL-2-(2-METHYLPHENYL)ETHYL]AMINO}-1-HYDROXYETHYL]-5-HYDROXY-2H-1,4-BENZOXAZIN-3(4H)-ONE'>P0G</scene></td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR, E ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10665 Enterobacteria phage T4])</td></tr> | ||
+ | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3p0g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3p0g OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3p0g RCSB], [http://www.ebi.ac.uk/pdbsum/3p0g PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | G protein coupled receptors (GPCRs) exhibit a spectrum of functional behaviours in response to natural and synthetic ligands. Recent crystal structures provide insights into inactive states of several GPCRs. Efforts to obtain an agonist-bound active-state GPCR structure have proven difficult due to the inherent instability of this state in the absence of a G protein. We generated a camelid antibody fragment (nanobody) to the human beta(2) adrenergic receptor (beta(2)AR) that exhibits G protein-like behaviour, and obtained an agonist-bound, active-state crystal structure of the receptor-nanobody complex. Comparison with the inactive beta(2)AR structure reveals subtle changes in the binding pocket; however, these small changes are associated with an 11 A outward movement of the cytoplasmic end of transmembrane segment 6, and rearrangements of transmembrane segments 5 and 7 that are remarkably similar to those observed in opsin, an active form of rhodopsin. This structure provides insights into the process of agonist binding and activation. | ||
- | + | Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor.,Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, Devree BT, Rosenbaum DM, Thian FS, Kobilka TS, Schnapp A, Konetzki I, Sunahara RK, Gellman SH, Pautsch A, Steyaert J, Weis WI, Kobilka BK Nature. 2011 Jan 13;469(7329):175-80. PMID:21228869<ref>PMID:21228869</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
==See Also== | ==See Also== | ||
*[[Adrenergic receptor|Adrenergic receptor]] | *[[Adrenergic receptor|Adrenergic receptor]] | ||
- | *[[ | + | *[[Antibody|Antibody]] |
- | + | *[[Lysozyme 3D structures|Lysozyme 3D structures]] | |
- | == | + | == References == |
- | < | + | <references/> |
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Enterobacteria phage t4]] | [[Category: Enterobacteria phage t4]] | ||
[[Category: Lama glama]] | [[Category: Lama glama]] | ||
Line 21: | Line 30: | ||
[[Category: Nanobodies]] | [[Category: Nanobodies]] | ||
[[Category: RCSB PDB Molecule of the Month]] | [[Category: RCSB PDB Molecule of the Month]] | ||
- | [[Category: Casarosa, P | + | [[Category: Casarosa, P]] |
- | [[Category: Chae, P S | + | [[Category: Chae, P S]] |
- | [[Category: Choi, H J | + | [[Category: Choi, H J]] |
- | [[Category: DeVree, B T | + | [[Category: DeVree, B T]] |
- | [[Category: Fung, J J | + | [[Category: Fung, J J]] |
- | [[Category: Gellman, S H | + | [[Category: Gellman, S H]] |
- | [[Category: Kobilka, B K | + | [[Category: Kobilka, B K]] |
- | [[Category: Kobilka, T S | + | [[Category: Kobilka, T S]] |
- | [[Category: Konetzki, I | + | [[Category: Konetzki, I]] |
- | [[Category: Pardon, E | + | [[Category: Pardon, E]] |
- | [[Category: Pautsch, A | + | [[Category: Pautsch, A]] |
- | [[Category: Rasmussen, S G.F | + | [[Category: Rasmussen, S G.F]] |
- | [[Category: Rosenbaum, D M | + | [[Category: Rosenbaum, D M]] |
- | [[Category: Schnapp, A | + | [[Category: Schnapp, A]] |
- | [[Category: Steyaert, J | + | [[Category: Steyaert, J]] |
- | [[Category: Sunahara, R K | + | [[Category: Sunahara, R K]] |
- | [[Category: Thian, F S | + | [[Category: Thian, F S]] |
- | [[Category: Weis, W I | + | [[Category: Weis, W I]] |
- | + | ||
[[Category: Agonist]] | [[Category: Agonist]] | ||
[[Category: Beta-2 adrenoceptor]] | [[Category: Beta-2 adrenoceptor]] |
Revision as of 10:38, 9 December 2014
Structure of a nanobody-stabilized active state of the beta2 adrenoceptor
|
Categories: Enterobacteria phage t4 | Lama glama | Lysozyme | Nanobodies | RCSB PDB Molecule of the Month | Casarosa, P | Chae, P S | Choi, H J | DeVree, B T | Fung, J J | Gellman, S H | Kobilka, B K | Kobilka, T S | Konetzki, I | Pardon, E | Pautsch, A | Rasmussen, S G.F | Rosenbaum, D M | Schnapp, A | Steyaert, J | Sunahara, R K | Thian, F S | Weis, W I | Agonist | Beta-2 adrenoceptor | Gpcr | Hydrolase | Membrane | Membrane protein | Nanobody | Signaling protein